28 DEC

Augmenix to Present at the 36th Annual J.P. Morgan Healthcare Conference

PRESS RELEASE:

BEDFORD, Mass.–(BUSINESS WIRE)–December 28, 2017–

Augmenix, Inc. a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during prostate radiotherapy, today announced that it will present at the 36^th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Tuesday, January 9, 2018. John Pedersen, President and Chief Executive Officer, is scheduled to present at 3:30 p.m. PST.

About Augmenix, Inc.

Augmenix, Inc. is a privately held company based in the Boston area focused on the development and commercialization of radiation oncology products using its proprietary hydrogel technology. The company was founded by Incept LLC in 2008 and is funded by several leading venture capital groups. More information about Augmenix can be found at http://www.Augmenix.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171228005042/en/

Augmenix
Eileen Gardner, RN, 781-902-1625
egardner@augmenix.com

VentureBeat

Post Author: martin

Martin is an enthusiastic programmer, a webdeveloper and a young entrepreneur. He is intereted into computers for a long time. In the age of 10 he has programmed his first website and since then he has been working on web technologies until now. He is the Founder and Editor-in-Chief of BriefNews.eu and PCHealthBoost.info Online Magazines. His colleagues appreciate him as a passionate workhorse, a fan of new technologies, an eternal optimist and a dreamer, but especially the soul of the team for whom he can do anything in the world.